Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
The ARTfactory’s Actors Theatre will bring Every Brilliant Thing to the stage in an intimate, thought-provoking performance ...
3d
Hosted on MSNDelays in Diagnosing Generalized Myasthenia GravisHeightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...
Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.
Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...
4d
Irish Star on MSNJohnson & Johnson legal battle over baby powder's 'link to cancer' begins in $10 billion caseA $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to ...
In Alabama, the suicide rate among young people aged 10-14 has doubled in the last two decades, says a report from the Alabama State Department of Education, titled Youth Suicide: “The Silent Epidemic ...
The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
In Alabama, Washington shares the spotlight with friend-turned-rival Thomas Jefferson, the nation's third president and ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... That status goes to Johnson & Johnson's Spravato (esketamine), which was approved in March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results